换一批
换一批Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.
作者：
Mohsen,Malehmir [1]
;
Dominik,Pfister [2]
;
Suchira,Gallage [2]
;
Marta,Szydlowska [2]
;
Donato,Inverso [3]
;
Elena,Kotsiliti [4]
;
Valentina,Leone [2]
;
Moritz,Peiseler [5]
;
Bas G J,Surewaard [2]
;
Dominik,Rath [6]
;
Adnan,Ali [7]
;
Monika Julia,Wolf [8]
;
Hannah,Drescher [8]
;
Marc E,Healy [9]
;
Daniel,Dauch [10]
;
Daniela,Kroy [11]
;
Oliver,Krenkel [2]
;
Marlene,Kohlhepp [1]
;
Thomas,Engleitner [12]
;
Alexander,Olkus [1]
;
Tjeerd,Sijmonsma [13]
;
Julia,Volz [14]
;
Carsten,Deppermann [12]
;
David,Stegner [12]
;
Patrick,Helbling [12]
;
César,Nombela-Arrieta [15]
;
Anahita,Rafiei [16]
;
Martina,Hinterleitner [17]
;
Marcel,Rall [2]
;
Florian,Baku [18]
;
Oliver,Borst [2]
;
Caroline L,Wilson [19]
;
Jack,Leslie [19]
;
Tracy,O'Connor [19]
;
Christopher J,Weston [20]
;
Abhishek,Chauhan [20]
;
David H,Adams [20]
;
Lozan,Sheriff [13]
;
Ana,Teijeiro [14]
;
Marco,Prinz [11]
;
Ruzhica,Bogeska [11]
;
Natasha,Anstee [11]
;
Malte N,Bongers [21]
;
Mike,Notohamiprodjo [21]
;
Tobias,Geisler [5]
;
Dominic J,Withers [22]
;
Jerry,Ware [23]
;
Derek A,Mann [23]
;
Hellmut G,Augustin [23]
;
Alexandros,Vegiopoulos [24]
;
Michael D,Milsom [25]
;
Adam J,Rose [26]
;
Patricia F,Lalor [27]
;
Josep M,Llovet [28]
;
Roser,Pinyol [29]
;
Frank,Tacke [30]
;
Roland,Rad [31]
;
Matthias,Matter [30]
;
Nabil,Djouder [31]
;
Paul,Kubes [32]
;
Percy A,Knolle [32]
;
Kristian,Unger [33]
;
Lars,Zender [34]
;
Bernhard,Nieswandt [35]
;
Meinrad,Gawaz [36]
;
Achim,Weber [21]
;
Mathias,Heikenwalder [3]
作者单位：
Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
[1]
Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
[2]
Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
[3]
European Center of Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
[4]
Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
[5]
Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
[6]
Calvin Phoebe & Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
[7]
Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
[8]
Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
[9]
Department of Medical Microbiology, University Medical Center, Utrmeecht, the Netherlands.
[10]
Department of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
[11]
Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
[12]
Department of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.
[13]
Department of Physiology I, Institute of Physiology, Eberhard Karls University Tübingen, Tübingen, Germany.
[14]
Center for Translational Cancer Research (TranslaTUM), Technische Universität München, Munich, Germany.
[15]
Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
[16]
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
[17]
Medical Faculty, University of Heidelberg, Heidelberg, Germany.
[18]
Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
[19]
Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
[20]
Newcastle Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
[21]
Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Munich, Germany.
[22]
Centre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.
[23]
Liver Unit, University Hospitals Birmingham NHS Trust, Birmingham, UK.
[24]
Institute for Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
[25]
Cancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
[26]
Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
[27]
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
[28]
Center for NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
[29]
Division of Experimental Hematology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
[30]
DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH) Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
[31]
Department of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Tübingen, Germany.
[32]
Department of Cardiovascular Medicine, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
[33]
Metabolic Signalling Group, MRC London Institute of Medical Sciences, London, UK.
[34]
Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
[35]
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
[36]
DKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[37]
Nutrient Metabolism and Signalling Lab, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
[38]
Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Medicine, Department of Pathology, Recanati Miller Transplantation Institute), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
[39]
Liver Cancer Translational Research Laboratory, IDIBAPS, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain.
[40]
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
[41]
Institute of Pathology, University Hospital of Basel, Basel, Switzerland.
[42]
Translational Gastrointestinal Oncology Group, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
[43]
Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. achim.weber@usz.ch.
[44]
Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany. heikenwaelder@helmholtz-muenchen.de.
[45]
Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany. heikenwaelder@helmholtz-muenchen.de.
[46]
DOI
10.1038/s41591-022-01693-7
PMID
35181768
发布时间
2024-02-28
- 浏览0
Nature medicine
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
